Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Skin Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Colonic Polyps 1Colonic Neoplasms 1Colonic Diseases 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

aldesleukin 9Interleukin-2 9Nivolumab 7fludarabine phosphate 6Dacarbazine 6Cyclophosphamide 6fludarabine 5Temozolomide 4Ipilimumab 4Fluorouracil 4montanide ISA 51 3Surveys and Questionnaires 3Semaxinib 3Radiotherapy 3Radiation 3Mohs Surgery 3Educational Status 3Cisplatin 3Allovectin-7 3zanolimumab 2talabostat 2sonidegib 2poly ICLC 2binimetinib 2Whole-Body Irradiation 2Vinblastine 2Vemurafenib 2Tacrolimus 2Tablets 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Skin Neoplasms × Optical Imaging × Clear all
NCT01662713 2023-03-15

OFDI

Massachusetts General Hospital

Phase NA Completed
10 enrolled
Dermatologic

Skin Neoplasms

NCT00432471 2017-06-28

Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers

M.D. Anderson Cancer Center

Phase NA Completed
23 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡